Does ERTAPENEM Cause Macular degeneration? 776 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 776 reports of Macular degeneration have been filed in association with ERTAPENEM (INVANZ). This represents 19.1% of all adverse event reports for ERTAPENEM.
776
Reports of Macular degeneration with ERTAPENEM
19.1%
of all ERTAPENEM reports
0
Deaths
220
Hospitalizations
How Dangerous Is Macular degeneration From ERTAPENEM?
Of the 776 reports, 220 (28.4%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Macular degeneration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERTAPENEM. However, 776 reports have been filed with the FAERS database.
What Other Side Effects Does ERTAPENEM Cause?
Drug ineffective (1,001)
Off label use (372)
Product use in unapproved indication (346)
Pyrexia (279)
Nausea (277)
Confusional state (263)
Pain (255)
Malaise (220)
Weight decreased (220)
Therapeutic product effect incomplete (208)
What Other Drugs Cause Macular degeneration?
ADALIMUMAB (1,407)
CARBOXYMETHYLCELLULOSE (828)
PREGABALIN (826)
PREDNISONE (821)
BUDESONIDE (820)
MESALAMINE (810)
METRONIDAZOLE (796)
ATORVASTATIN (794)
ACETAMINOPHEN (793)
ALPRAZOLAM (792)
Which ERTAPENEM Alternatives Have Lower Macular degeneration Risk?
ERTAPENEM vs ERTUGLIFLOZIN PIDOLATE
ERTAPENEM vs ERYTHROMYCIN
ERTAPENEM vs ERYTHROMYCIN ETHYLSUCCINATE
ERTAPENEM vs ERYTHROMYCIN LACTOBIONATE
ERTAPENEM vs ERYTHROPOIETIN